BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 28986019)

  • 21. Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations.
    Ledder O; Haller W; Couper RT; Lewindon P; Oliver M
    J Gastroenterol Hepatol; 2014 Dec; 29(12):1954-62. PubMed ID: 25238538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutritional Status in the First 2 Years of Life in Cystic Fibrosis Diagnosed by Newborn Screening.
    Munck A; Boulkedid R; Weiss L; Foucaud P; Wizla-Derambure N; Reix P; Bremont F; Derelle J; Schroedt J; Alberti C;
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):123-130. PubMed ID: 29543697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis.
    Gould MJ; Smith H; Rayment JH; Machida H; Gonska T; Galante GJ
    J Cyst Fibros; 2022 Jul; 21(4):600-602. PubMed ID: 34732308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic enzyme replacement therapy in chronic pancreatitis.
    Sikkens EC; Cahen DL; Kuipers EJ; Bruno MJ
    Best Pract Res Clin Gastroenterol; 2010 Jun; 24(3):337-47. PubMed ID: 20510833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic enzyme replacement therapy for people with cystic fibrosis (Review).
    Somaraju UR; Solis-Moya A
    Paediatr Respir Rev; 2015 Mar; 16(2):108-9. PubMed ID: 25497671
    [No Abstract]   [Full Text] [Related]  

  • 26. Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency.
    Couper RT; Corey M; Moore DJ; Fisher LJ; Forstner GG; Durie PR
    Pediatr Res; 1992 Aug; 32(2):179-82. PubMed ID: 1508606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal outcomes and confounders in cystic fibrosis.
    Borowitz D; Durie PR; Clarke LL; Werlin SL; Taylor CJ; Semler J; De Lisle RC; Lewindon P; Lichtman SM; Sinaasappel M; Baker RD; Baker SS; Verkade HJ; Lowe ME; Stallings VA; Janghorbani M; Butler R; Heubi J
    J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):273-85. PubMed ID: 16131979
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by use of fluorescein dilaurate test.
    Cumming JG; Forsyth JS; Boyd EJ; Frost GJ; Cuschieri A
    Arch Dis Child; 1986 Jun; 61(6):573-5. PubMed ID: 3729527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescein dilaurate test of exocrine pancreatic function in cystic fibrosis.
    Dalzell AM; Heaf DP
    Arch Dis Child; 1990 Jul; 65(7):788-9. PubMed ID: 2386387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic involvement in cystic fibrosis.
    Ozen Alahdab Y; Duman DG
    Minerva Med; 2016 Dec; 107(6):427-436. PubMed ID: 27425634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on the evaluation of pancreatic exocrine status in cystic fibrosis.
    Borowitz D
    Curr Opin Pulm Med; 2005 Nov; 11(6):524-7. PubMed ID: 16217179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic Exocrine Insufficiency in Pancreatic Cancer.
    Vujasinovic M; Valente R; Del Chiaro M; Permert J; Löhr JM
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28241470
    [No Abstract]   [Full Text] [Related]  

  • 33. [Physiopathology, diagnosis, and treatment of exocrine pancreatic insufficiency after acute pancreatitis].
    Martínez Sempere J; Pérez-Mateo M
    Gastroenterol Hepatol; 2005 Feb; 28 Suppl 1():16-21. PubMed ID: 15899233
    [No Abstract]   [Full Text] [Related]  

  • 34. Tubeless tests of exocrine pancreatic function in patients with cystic fibrosis.
    Lamers CB
    Neth J Med; 1992 Oct; 41(3-4):101-4. PubMed ID: 1470277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic Malnutrition in Children.
    Normatov I; Sentongo T
    Pediatr Ann; 2019 Nov; 48(11):e441-e447. PubMed ID: 31710363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic pancreatitis in a patient with cystic fibrosis and clinical pancreatic insufficiency.
    del Rosario JF; Putnam PE; Orenstein DM
    J Pediatr; 1995 Jun; 126(6):951-2. PubMed ID: 7776104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of pancreatic status on circulating plasma sterols in patients with cystic fibrosis.
    Gelzo M; Iacotucci P; Sica C; Liguori R; Comegna M; Carnovale V; Dello Russo A; Corso G; Castaldo G
    Clin Chem Lab Med; 2020 Sep; 58(10):1725-1730. PubMed ID: 32083440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and management of pancreatic exocrine insufficiency.
    Nikfarjam M; Wilson JS; Smith RC;
    Med J Aust; 2017 Aug; 207(4):161-165. PubMed ID: 28814218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of the pancreas in cystic fibrosis.
    Durie PR
    Neth J Med; 1992 Oct; 41(3-4):97-100. PubMed ID: 1470291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes.
    Radlinger B; Ramoser G; Kaser S
    Curr Diab Rep; 2020 Apr; 20(6):18. PubMed ID: 32239341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.